Nevertheless, it was reported that up to 80% of osteosarcoma patient samples exhibit a “BRCAness,” indicating that they share similarities to tumours harbouring germline mutations in BRCA1 or BRCA2 making them deficient in DNA repair pathways [77]. This evidence concerns the gene BRCA2 and neoplasm.